First and foremost, CB1R activation inhibits excitotoxicity by curtailing excessive glutamate release, a major contributor to neuronal injury and death in stroke, working in tandem with metabotropic glutamate receptor 5 (mGluR5) to safeguard against glutamate-induced toxicity, suggesting a role in preserving synaptic function. Here, GRM5 is linked to stroke disorder.